Global Healthcare Industry Research

Expected Revenue Growth: The transdermal drug delivery systems market is projected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period of 2018 to 2023. Major Growth Boosters: Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug ..

카테고리 없음 2020. 12. 11. 17:46

Recent Developments in the Global Industry: # In January 2018, Hisamitsu Pharmaceutical (Japan) launched ALLESAGA TAPE in the Japanese market. # In July 2018, UCB (Belgium) received the Import Drug License (IDL) for its transdermal rotigotine patch—NEUPRO from the China Food and Drug Administration (CFDA). # In August 2018, Luye Pharma (China) signed an agreement with Bayer AG (Switzerland) to a..

카테고리 없음 2020. 9. 30. 16:23

Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug delivery systems are also expected to support market growth in the coming years. The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the f..

카테고리 없음 2020. 9. 29. 17:44